Latest Breaking News On - David lebwohl - Page 1 : comparemela.com

Intellia Therapeutics, Inc (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript

Intellia Therapeutics, Inc (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesYanan zhuDebjit chattopadhyayKostas biliourisLaura sepp lorenzinoIan karpGlenn goddardJohn leonardDavid lebwohlBrian chengTroy langfordMaury raycroftGina wangBenazir aliDrug administrationCorporate communications at intellia

Seven Eight Capital LP Buys 7,549 Shares of Intellia Therapeutics, Inc (NASDAQ:NTLA)

Seven Eight Capital LP Buys 7,549 Shares of Intellia Therapeutics, Inc (NASDAQ:NTLA)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Johnm leonardDavid lebwohlTower research capitalGoldman sachs groupGroup plcSecurities exchange commissionIntellia therapeutics incCanaccord genuity groupMerlin capital incWolfe researchAmeriprise financial incExchange commissionCorton capital incSeven eight capitalIntellia therapeuticsFree report

Intellia Therapeutics (NASDAQ:NTLA) Shares Up 11 3%

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report)’s stock price traded up 11.3% during trading on Tuesday . The company traded as high as $31.13 and last traded at $30.79. 2,174,127 shares changed hands during trading, an increase of 39% from the average session volume of 1,563,047 shares. The stock had previously closed at $27.66. […]

Johnm leonardDavid lebwohlMorgan stanleyGroup wealth managementPenserra capital managementIntellia therapeutics incBlue trust incCanaccord genuity groupSecurities exchange commissionIntellia therapeutics company profileGoldman sachs groupIntellia therapeuticsGet free reportGenuity groupExchange commissionInvestment management

Intellia Therapeutics (NASDAQ:NTLA) Announces Quarterly Earnings Results

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) posted its earnings results on Thursday. The company reported ($1.46) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.01, Briefing.com reports. The business had revenue of ($1.92) million during the quarter, compared to analyst estimates of $15.10 million. Intellia Therapeutics had a negative return on […]

Hong kongLaura sepp lorenzinoRaymond jamesDavid lebwohlSecurities exchange commissionHong kong ltdWealth managementLife insurance coRoyal bankIntellia therapeutics company profileTower research capitalFinancial services group incCanaccord genuity groupIntellia therapeutics incWolfe researchIntellia therapeutics

Intellia Therapeutics (NASDAQ:NTLA) Releases Earnings Results, Beats Expectations By $0 01 EPS

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) issued its earnings results on Thursday. The company reported ($1.46) earnings per share for the quarter, topping the consensus estimate of ($1.47) by $0.01, Briefing.com reports. Intellia Therapeutics had a negative return on equity of 43.31% and a negative net margin of 893.34%. The business had revenue of […]

Nova scotiaDavid lebwohlJohnm leonardVanguard group incIntellia therapeutics incRoyal bankMorgan stanleyBlackrock incPricet rowe associates incSecurities exchange commissionIntellia therapeuticsGet free reportTherapeutics stock downExchange commissionStreet corpPricet rowe associates